Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells

Journal of Medical Virology

Volumn 78, Issue 12, 2006, Pages 1616-1623

  Komatsu, Haruki ^a,b   Kogawa, Kazuhiro ^b   Nonoyama, Shigeaki ^b   Inui, Ayno ^c   Sogo, Tsuyoshi ^c   Fujisawa, Tomoo ^c   Klenerman, Paul ^d  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c International University of Health and Welfare   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone marrow transplantation; Cytomegalovirus; Human leucocyte antigen; IFN enzyme linked immunospot; Tetramer

Indexed keywords

ASPARAGINYLLEUCYLVALYLPROLYLMETHIONYLVALYLALANYLTHREONYLVALINE; CD8 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CASE REPORT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; SCREENING TEST;

BLOOD DONORS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; PHENOTYPE; SIBLINGS; STAINING AND LABELING; TRANSPLANTATION, HOMOLOGOUS;

CYTOMEGALOVIRUS;

EID: 33750572203     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20746     Document Type: Article

References (33)

1. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
2. Boeckh M, Gooley TA, Reusser P, Buckner CD, Bowden RA. 1995. Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation. J Infect Dis 172:939-943.
3. Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L. 1999. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 93:1781-1782.
4. Boeckh M, Nichols WG. 2003a. Immunosuppressive effects of beta-herpesviruses. Herpes 10:12-16.
5. Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, Stevens-Ayers T, Flowers ME, Cunningham T, Corey L. 2003b. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity. Blood 101:407-414.
6. Boeckh M, Nichols WG. 2004. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 103:2003-2008.
7. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, Forster R, Rowland-Jones S, Sekaly RP, McMichael AJ, Pantaleo G. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-111.
8. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P, Fagiolo U, Castellani G, Bersani F, Londei M, Franceschi C. 1996. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: Implications for T cell memory. Mech Ageing Dev 86:173-195.
9. Cwynarski K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J, Goldman J, Craddock C, Moss PA. 2001. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97:1232-1240.
10. Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, Loffler J, Grigoleit U, Moris A, Rammensee HG, Kanz L, Kleihauer A, Frank F, Jahn G, Hebart H. 2002. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99:3916-3922.
11. Engstrand M, Tournay C, Peyrat MA, Eriksson BM, Wadstrom J, Wirgart BZ, Romagne F, Bonneville M, Totterman TH, Korsgren O. 2000. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 69:2243-2250.
12. Goulder PJ, Tang Y, Brander C, Betts MR, Altfeld M, Annamalai K, Trocha A, He S, Rosenberg ES, Ogg G, O'Callaghan CA, Kalams SA, McKinney RE Jr, Mayer K, Koup RA, Pelton SI, Burchett SK, McIntosh K, Walker BD. 2000. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med 192:1819-1832.
13. Gratama JW, van Esser JW, Lamers CH, Tournay C, Lowenberg B, Bolhuis RL, Cornelissen JJ. 2001. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98:1358-1364.
14. Hamann D, Roos MT, van Lier RA. 1999. Faces and phases of human CD8 T-cell development. Immunol Today 20:177-180.
15. Kern F, Surel IP, Brock C, Freistedt B, Radtke H, Scheffold A, Blasczyk R, Reinke P, Schneider-Mergener J, Radbruch A, Walden P, Volk HD. 1998. T-cell epitope mapping by flow cytometry. Nat Med 4:975.
16. Klenerman P, Cerundolo V, Dunbar PR. 2002. Tracking T cells with tetramers: New tales from new tools. Nat Rev Immunol 2:263-272.
17. Komatsu H, Inui A, Sogo T, Fujisawa T, Nagasaka H, Nonoyama S, Sierro S, Northfield J, Lucus M, Vargas A, Klenerman P. Large scale analysis of pediatric antiviral CD&T T cell populations reveals sustained, functional, and mature responses (in press).
18. Larsson K, Aschan J, Remberger M, Ringden O, Winiarski J, Ljungman P. 2004. Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus. Transplantation 77:526-531.
19. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979.
20. Ljungman P. 2002. Beta-herpesvirus challenges in the transplant recipient. J Infect Dis 186:S99-S109.
21. Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. 2003. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: An EBMT megafile analysis. Blood 102:4255-4260.
22. Miller W, Flynn P, McCullough J, Balfour HH Jr, Goldman A, Haake R, McGlave P, Ramsay N, Kersey J. 1986. Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-v-host disease. Blood 67:1162-1167.
23. Nguyen Q, Champlin R, Giralt S, Rolston K, Raad I, Jacobson K, Ippoliti C, Hecht D, Tarrand J, Luna M, Whimbey E. 1999. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis 28:618-623.
24. Okumura M, Fujii Y, Inada K, Nakahara K, Matsuda H. 1993. Both CD45RA+ and CD45RA subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J Immunol 150:429-437.
25. Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV. 2002. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 100:3690-3697.
26. Peggs K, Verfuerth S, Mackinnon S. 2001. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: A novel culture system free of live CMV virions. Blood 97:994-1000.
27. Reusser P, Riddell SR, Meyers JD, Greenberg PD. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
28. Singhal S, Shaw JC, Ainsworth J, Hathaway M, Gillespie GM, Paris H, Ward K, Pillay D, Moss PA, Mutimer DJ. 2000. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation 69:2251-2259.
29. Szmania S, Galloway A, Bruorton M, Musk P, Aubert G, Arthur A, Pyle H, Hensel N, Ta N, Lamb L Jr, Dodi T, Madrigal A, Barrett J, Henslee-Downey J, van Rhee F. 2001. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 98:505-512.
30. Wagner JA, Ross H, Hunt S, Gamberg P, Valentine H, Merigan TC, Stinson EB. 1995. Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. Transplantation 60:1473-1477.
31. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038-1044.
32. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70:7569-7579.
33. high in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J Immunol 162:7080-7087.